Korkmaz-Balli2021 Article ClinicalEvaluationOfTheTreatme
Korkmaz-Balli2021 Article ClinicalEvaluationOfTheTreatme
Korkmaz-Balli2021 Article ClinicalEvaluationOfTheTreatme
https://doi.org/10.1007/s00784-021-03935-3
ORIGINAL ARTICLE
Received: 7 December 2020 / Accepted: 30 March 2021 / Published online: 8 April 2021
# The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021
Abstract
Objective To assess the effectiveness of the combination of tunnel technique (TT) and concentrated growth factor (CGF) for root
coverage in treating multiple gingival recessions (GR) and compare with the connective tissue graft (CTG).
Materials and methods Forty patients with Miller Class I and II maxillary or mandibular GR were randomly divided into two
groups as follows: TT + CTG and TT + CGF. The results at baseline and 6 months were evaluated for the following clinical
parameters: complete root coverage (CRC), mean root coverage (MRC), gingival thickness (GT), gingival recession width (RW),
gingival recession depth (RD), and keratinized tissue width (KTW).
Results At 6 months, a statistically significant difference was found in RD, RW, MRC, CRC, KTW, and GT compared with the
baseline (p < 0.05). MRC was determined 89.52±16.36% in the TT + CTG and 76.60±24.10% in the TT + CGF (p < 0.05). CRC
was achieved in 66.7% of the TT + CTG and 47.4% of the TT + CGF (p < 0.05). The increase in KTW and GT was significantly
better in the TT + CTG group compared to the TT + CGF (p < 0.05).
Conclusions The study showed that TT + CGF did not improve the results as much as TT + CTG in the treatment of Miller Class I
and II GR. However, this finding is not sufficient to advocate the true clinical effects of CGF on GR treatment with TT.
Clinical relevance CGF could not serve as a direct alternative biomaterial to the gold standard CTG.
Trial registration ClinicalTrials.gov Identification Number: NCT04561947
Keywords Gingival recession . Growth factors . Plastic periodontal surgery . Connective tissue graft
Introduction and inability to always achieve the graft of the desired size [4,
5]. To overcome these disadvantages, attempts have been
Many techniques and biomaterials have been used for treat- made to search for materials alternative to CTG [1, 6]. One
ment of gingival recessions (GR) [1]. Connective tissue graft of these materials is platelet concentrates (PCs) [7–9].
(CTG) and coronally advanced flap (CAF) have been accept- Growth factors (GFs) released from platelets are important
ed as the most effective surgical techniques in regard to root for wound healing and increase cell angiogenesis, prolifera-
coverage predictability and long-term stability and have been tion, and extracellular matrix synthesis [10]. Therefore, the
stated as the gold standard [1–3]. In some cases, the disadvan- use of platelet-derived GFs for tissue regeneration in peri-
tages of CTG are inadequate palate tissue thickness, creating a odontal plastic surgery has been suggested [6, 7].
secondary surgical area that increases morbidity for a patient, Concentrated growth factor (CGF) is obtained by centrifuging
venous blood in a special centrifuge device at varying speeds
(2400 to 3000 rpm) [11]. In CGF isolation, the modified speed
* Birsen Korkmaz ratio is used rather than the constant speed used while obtaining
[email protected] platelet-rich fibrin (PRF). Thus, it is stated that a dense matrix is
formed in a way that allows increase of GF release [12].
1
Department of Periodontology, Faculty of Dentistry, Bulent Ecevit
CGF contains thrombocytes, leukocytes, and abundant
University, Zonguldak, Turkey GFs including transforming growth factor-beta 1 (TGF-β1),
2
Department of Periodontology, Faculty of Dentistry, Bezmialem
platelet-delivered growth factor (PDGF), vascular endothelial
Vakif University, Istanbul, Turkey growth factor (VEGF), insulin-like growth factors (IGF),
6348 Clin Oral Invest (2021) 25:6347–6356
fibroblast growth factor (FGF), and bone morphogenic protein To the best of our knowledge, this is the first study which
(BMP) in a complex three-dimensional fibrin network [11, 13, compares CGF and CTG in terms of root coverage efficiency
14]. This fibrin network is highly cohesive due to the presence using TT. The aim of this study was to evaluate the success of
of thrombin, factor XIII, and fibrinogen. Factor XIIIa, activat- CGF with TT and to compare it with the gold standard CTG in
ed by thrombin, causes the coagulation of fibrin. This protects the treatment of GR.
the clot from plasmin degradation and provides high tensile
strength and stability [11, 15].
Some studies have reported the biological and mechanical Materials and methods
advantages of CGF compared with PRF. CGF has a rigid tex-
ture thanks to its interwoven fiber structure [16, 17]. The fibrin Study design
matrix of CGF is larger and denser and contains more GF as a
result of different centrifuge speeds [18]. Lee et al. stated that This study was a single-center, parallel-group design, random-
CGF has stronger tensile strength and higher potential to induce ized controlled clinical study including 40 individuals who
proliferation of osteoblast and gingival fibroblast compared applied to the Department of Periodontology, Bulent Ecevit
with PRF [19]. Moreover, the GFs are homogeneously distrib- University, between October 2017 and July 2018. The study
uted in the plasma protein layer of CGF, and the release of the protocol in accordance with Declaration of Helsinki, as
GFs is for a longer duration compared with that for the usual revisited in 2000, was approved by Clinical Research Ethics
fibrin clot because of the fibrin matrix [20, 21]. The high tensile Committee of University with the protocol number 2017-82-
strength and viscosity of CGF protect GFs from proteolysis and 09/08 (ClinicalTrials.gov ID: NCT04561947).
prolong the release time of GFs [15]. GFs release due to con-
tinuous collision and rupture of platelets increases during cen- Sample size calculation
trifugation in the preparation of CGF [22]. Studies have shown
that CGF is slowly dissolved and released GFs for more than Data in two studies were used as guide to estimate sample size
13 days [21, 23]. Thus, CGF functions as a biomaterial that is a calculation [33, 34]. According to difference in root coverage
reservoir of integrated GFs [24]. of 1±0.9 mm (80% power which is equal β = 0.20 type II error
Many studies have shown the bioactivity, GFs content, and level with 5% type I error level which is equal α = 0.05
GFs release times of CGF [15, 16, 24, 25]. CGF stimulates the probability level), 14 participants in every group were needed.
proliferation, osteogenic maturation, and mineralization of In addition to these 14 participants, six more were recruited for
mesenchymal stem cells. Also, it has a good regenerative ca- each group to make up for any potential withdrawals.
pacity and versatility by increasing proliferation of the peri-
odontal ligament stem cells [26]. The high regeneration, vas- Investigator calibration
cularization, and angiogenesis capacity of CGF may be asso-
ciated with the presence of CD34 (+) cells [11, 12, 22]. The investigator calibration was provided to determine the
CGF is used in a wide variety of application areas, includ- repeatability of clinical measurements made by the researcher.
ing extraction sockets, sinus-lifting operations, alveolar ridge For this purpose, clinical measurements were made twice at an
augmentation, treatment of GR, and guided bone regenera- interval of 72 h in 20 defects of 5 patients. The repeatability of
tion, and achieved good results [8, 22, 27]. the measurements made by the researcher using the correla-
Scientific and technical innovations in the field of peri- tion coefficient was determined as 90% [7].
odontal plastic surgery and the increasing aesthetic expecta-
tions of patients have enabled the development of existing Patient population
treatment approaches. These developments have focused es-
pecially on wound healing and on increasing the blood supply The inclusion criteria were as follows: (1) age ≥ 18 years; (2)
of the treated area [28]. It is believed that the tunnel technique periodontally and systemically healthy; (3) presence of Miller
(TT), in which vertical releasing incisions are not performed, Class I or II GR defects in at least two teeth on the buccal
provides better nutrition to the area because of the blood sup- aspect of maxillary or mandibular incisors, canines, and pre-
ply provided to the flap and graft. Moreover, the aesthetic molars (≥ 2 mm in depth); (4) gingival thickness (GT) ≥
results are considered to develop due to avoiding the 0.8 mm at 2 mm apical from gingival margin; (5) presence
use of vertical incisions and no dissection of the papil- of identifiable cementoenamel junction (CEJ) (step ≤ 1 mm at
lae [29]. The TT is reported to provide some advantages the CEJ level and/or presence of a root irregularity/abrasion
such as reduced patient morbidity and faster and earlier with identifiable CEJ was accepted); (6) full-mouth plaque
healing [30–32]. The use of TT and its modifications score (FMPS) and full-mouth bleeding score (FMBS) ≤
for treatment of GR have been reported to provide high- 20%. The exclusion criteria were as follows: (1) smoking;
ly effective and aesthetic results [28, 29]. (2) contraindications for surgical periodontal treatment; (3)
Clin Oral Invest (2021) 25:6347–6356 6349
presence of recession defects associated with caries, restora- to advance the flap in the coronal direction and prevent the
tion, and deep abrasion; (4) use of systemic antibiotics for any collapse of the sutures on the interproximal areas.
reason in the last 3 months; (5) pregnant or lactating women. The patients were randomly assigned to one of the two
The study plan was explained to the patients by giving treatment groups by the flip of a coin by an independent third
detailed information about the treatments to be applied before person immediately before the surgery. After local anesthesia,
any procedure, and the informed consent forms were signed. the exposed root surfaces were mechanically treated with cu-
Four weeks prior to surgery, all patients were given detailed rettes (Gracey Curettes, Hu-Friedy, Chicago, IL, USA).
oral hygiene instructions to modify their oral hygiene habits. Tunneling knives (Stoma, Emmingen-Liptingen, Germany)
The full-mouth professional tooth cleaning was performed. were used to prepare a split-thickness flap and create a con-
The patients were re-evaluated; if they met the inclusion tinuous tunnel in the buccal soft tissues, following the
criteria, they were scheduled for the surgical periodontal treat- intrasulcular incision with a microblade (69 WS Swann-
ment. TT + CTG was applied to 20 patients in the control Morton, Sheffield, England). Split-thickness flap preparation
group (51 defects) and TT + CGF was applied to 20 patients was performed beyond the mucogingival junction with
in the test group (57 defects). supraperiosteal dissection by placing the tunneling knives to
the soft tissue. This process was repeated by entering through
Primary and secondary outcome variables the sulcus of each tooth. After the elevation of the flap, a
papilla elevator placed under the flap was entered through
Complete root coverage (CRC) was established as the primary the sulcus to mobilize the papilla, the periosteum at the base
outcome variable, while mean root coverage (MRC), GT, gin- of the papilla was cut, and the full-thickness flap was elevated.
gival recession width (RW), gingival recession depth (RD), Thus, the entire buccal soft tissue complex was mobilized
and keratinized tissue width (KTW) were the secondary out- coronally.
come variables.
Results
CRC: CRC was achieved in 34 (66.7%) of 51 defects in the addition to GR treatment might have positive effects, shorten-
control group and 27 (47.4%) of 57 defects in the test group. ing the surgical time in patients requiring large amounts of
The difference between the groups was statistically significant CTG, and could be a potential alternative [44]. Many studies
in favor of the control group (p = 0.043) (Table 2). comparing CAF with CTG and PRF suggested that PRF
showed good results for all parameters and could be a success-
ful alternative to the gold standard CTG [45].
Discussion A recent meta-analysis reported that PRF used in addition
to CAF surgery was associated with higher percentage of root
GFs are bioactive proteins secreted by platelets, which control coverage, but did not create a significant change in terms of
wound healing [40]. Clinical outcomes can be improved with KTW. Studies comparing CTG and PRF achieved better re-
the use of GFs in the treatment of GR [41]. Limited data exist sults in the CTG group in terms of KTW and percentage of
on the use of CGF, the new-generation PC, in the treatment of root coverage, and CTG was a better option in patients with
GR compared with the commonly used PRF [8, 42]. This KTW insufficiency and deficiency [46].
randomized controlled clinical trial was designed to evaluate Based on the available information and results, it was still
the effectiveness of TT + CGF in the treatment of multiple not possible to clearly conclude about the use of PRF in the
Miller Class I/II GR and whether CGF was an alternative treatment of GR. The variety of results could be explained
biomaterial to CTG. The results showed that both techniques considering different PRF properties resulting from different
were effective in the treatment of GR, but better results were PRF preparation protocols, process of collecting blood, cell
obtained in the CTG group in terms of KTW, GT, and root counts, and concentrations of GFs [47].
coverage percentages at 6 months. Unlike other PCs, CGF is obtained with a centrifuge pro-
The results of studies comparing CTG and PC were con- tocol at varying speeds in a special centrifuge device (accel-
tradictory. A systematic review evaluating the effects of PC on erated for 30 s; centrifuged at 2700 rpm × 2 min, 2400 rpm × 4
surgical periodontal treatment results reported that PC did not min, 2700 rpm × 4 min, and 3000 rpm × 3 min; and deceler-
provide a significant benefit in the treatment of GR [43]. ated for 36 s to stop) [11]. The centrifuge devices and proto-
Another systematic review showed that the use of PC in cols used for PRF production vary considerably. The changes
to be made in centrifuge speed and time might affect the achieved with both techniques [54]. In the 6-month results of
PRF’s cell content and number, growth factor, and fibrin ma- their study comparing the modified TT + CTG and the mod-
trix directly; change its biological activities; and cause differ- ified TT + titanium-prepared PRF (T-PRF), Uzun et al. [9]
ences in clinical results [48, 49]. In this respect, it has been showed the MRC was 91.06% for T-PRF and 92.04% for
reported that CGF may be more stable and suitable for acquir- CTG, with no difference between groups. In the 12th month
ing predictable results since CGF is obtained with more con- results of their study, the MRC was reported to be 93.29% for
sistent centrifuge protocols [50]. the T-PRF and 93.22% for the CTG group; the results obtain-
CTG is still the most suitable graft material in the treatment ed at the end of the study period were stable. The MRC and
of gingival recession. However, it causes increased patient CRC in the present study were lower than those in their study.
morbidity [4, 5]. PRF has positive effects on wound healing The details of TT in their study indicated that the researchers
in various soft tissue defects and reduces postoperative pain used a 3-mm vertical incision in the alveolar mucosa close to
and discomfort regardless of the type of PRF used [51, 52]. In base of the vestibule. No vertical incision was used in the TT
addition, it is easy to use and inexpensive, and requires less applied in the present study. It was believed that this situation
time. PRF should be considered a living tissue for natural might directly affect the CRC and MRC. The lower MRC and
guided tissue regeneration rather than just a growth factor– CRC in the present study may be related to the different sur-
rich surgical adjuvant [52]. With these advantages, the use gical approaches used.
of PRF and/or CGF in treatment of gingival recession may In a study evaluating the effect of CTG thickness on surgi-
be effective. cal outcomes, no statistically significant differences were
In the present study, MRC and CRC were found to be found between the 1 mm and 2 mm thick groups, but a ten-
89.52% and 66.7%, respectively, in the CTG group and dency for improved outcomes in terms of root coverage, GT,
76.6% and 47.4%, respectively, in the CGF group. The and KTW for 2 mm thick CTG is noted in the third month
MRC and CRC values in the TT + CTG group in this study [55]. In the treatment of gingival recessions, PRF should be
were compatible with the recent systematic review [53]. In a applied in at least two layers, if possible in three layers, so that
study by Bozkurt Dogan et al. [8], MRC and CRC were re- the desired volume is reached [56]. Studies on this subject are
ported as 86.67% and 45.8%, respectively, in the CAF + CGF limited. Culhaoğlu et al. [57] obtained much better results
group, with no significant difference between the groups. with 4 PRF layers than with 2 PRF layers in terms of root
They stated that CGF did not provide an additional benefit coverage in the treatment of gingival recessions and found
in terms of root coverage. Akcan and Unsal [42] in their study that the effects of 4 PRF layers and CTG were similar. In
comparing CAF + CTG and CAF + CGF stated the MRC is the present study results, this situation might affect obtaining
52.45% for the CGF group and 72.45% for the CTG group. lower MRC, CRC, and GT values with CGF compared with
They reported that CTG provided superior results in terms of CTG. Increasing the layer of CGF can improve these results;
GT, KTW, and root coverage, but CGF was more preferable however, further studies testing this hypothesis are needed.
in reducing postoperative pain. According to these results, In the current study, the mean KTW increased from 2.10 ±
although CGF did not improve the outcomes of root coverage, 0.49 to 4.80 ± 0.57 mm in the TT + CTG group and from 2.26
it is not possible to reach a clear conclusion due to insufficient ± 0.40 to 2.81 ± 0.56 mm in the TT + CGF group; this increase
clinical evidence. In a case report, multiple Miller Class II GR was statistically significantly higher in the CTG group. In the
were treated with TT + PRF and TT + CTG and followed up present study, as in previous studies, KTW increased in the
for 45 days, revealing that successful root coverage (90%) was CGF group [8, 42]. Akcan and Unsal [42] demonstrated a
Fig. 5 Control group. a Preoperative view. b 6 months postoperative view Fig. 6 Test group. a Preoperative view. b 6 months postoperative view
Clin Oral Invest (2021) 25:6347–6356 6353
Table 1 Descriptive statistics of the clinical parameters measured at the increase in the groups in the present study were consistent
baseline and 6 months after the surgery
with previous studies [57–59]. Many GFs released from plate-
Control group (n = 51) Test group (n = 57) p value lets in the natural fibrin matrix of PRF increased KTW by
Mean ± SD Mean ± SD positively affecting the proliferation of gingival/periodontal
fibroblasts [7, 60]. Based on these studies, it is presumed that
PD
CGF, which contains more GFs [11, 22], may have a similar
Baseline 1.42 ± 0.41 1.37 ± 0.26 0.834
effect. The increase in KTW in the CTG group could be ex-
6 months 1.37 ± 0.40 1.26 ± 0.35 0.314
plained by the ability of CTG to induce the keratinization of
p value 0.284 0.103
the epithelium [61].
CAL
In the present study, an increase of 0.94 ± 0.05 mm in the
Baseline 3.96 ± 0.67 3.83 ± 0.56 0.482 CTG group and 0.26 ± 0.09 mm in the CGF group was ob-
6 months 1.64 ± 0.48 1.88 ± 0.59 0.225 served in the GT values, and this increase was found to be
p value 0.000* 0.000* significantly higher in the CTG group. Studies have reported
RD that the use of CGF increases GT significantly [8, 42]. Most
Baseline 2.53±0.66 2.45±0.45 0.805 studies showed that PRF increased GT values, but better re-
6 months 0.26±0.34 0.62±0.57 0.053 sults were obtained in the CTG group [9, 57]. The results of
p value 0.000* 0.000* the present study were compatible with previous studies. The
RW increase in GT with PRF might be due to the proliferative
Baseline 3.56±0.51 3.37±0.37 0.222 effect of GFs on gingival/periodontal fibroblasts or the space
6 months 1.14±0.99 1.13±1.43 0.585 provided by the PRF membrane with histoconduction [7, 9].
p value 0.000* 0.000* The significant increase in GT in the CTG group compared
KTW with the CGF group may be explained by that CGF does not
Baseline 2.10±0.49 2.26±0.40 0.722 serve as good scaffold supporting the migration of cells from
6 months 4.80±0.57 2.81±0.56 0.000* adjacent tissues.
p value 0.000* 0.000* A meta-analysis reported no difference between CTG and
GT PRF in terms of PD and CAL [46]. In this study, the decrease
Baseline 1.16±0.05 1.19±0.05 0.101 in PD values and the significant increase in CAL obtained in
6 months 2.10±0.10 1.45±0.14 0.000* both groups were compatible with those in other studies [7, 8].
p value 0.000* 0.000* More reliable results could be obtained with the split-
mouth design to minimize the individual differences depend-
CAL, clinical attachment level; GT, gingival thickness; KTW, keratinized
ing on patient. In such a manner, the inter-patient influence on
tissue width; PD, probing depth; RD, recession depth; RW, recession
width post-surgical wound healing could be reduced for both surgi-
Data are expressed as the mean ± standard deviation cal procedures. This study had some limitations. First, this
Wilcoxon signed-rank test study was designed as parallel group, but initial RD, RW,
*
p < 0.05 GT, and KTW values were similar in both groups, minimizing
the negative effect of this factor. In addition, the results of this
study were limited to only short 6 months follow-up period,
statistically significant increase in KTW in the CTG group and patient-related outcomes (such as pain, patient satisfac-
compared with CGF. Many studies reported that the use of tion, and aesthetics) were not evaluated. Another limitation of
CTG increased the KTW more statistically significantly com- this study was that histological analysis was not performed to
pared with PRF, and the use of CTG to increase KTW was a evaluate the regenerative capacity of CGF. Therefore, no com-
more suitable option [46, 57–59]. Thus, the results on KTW ments could be made on the type of tissue formed.
Most studies evaluating the use of CGF/PRF for the treat- References
ment of gingival recessions CAF was preferred. Future studies
should investigate the effectiveness of CGF/PRF in root cov- 1. Chambrone L, Tatakis D (2015) Periodontal soft tissue root cover-
age procedures: a systematic review from the AAP Regeneration
erage when used with other surgical techniques other than the
Workshop. J Periodontol 86(2):8–51. https://doi.org/10.1902/jop.
CAF. The possible effect of different surgical approaches on 2015.130674
the results needs to be evaluated. It may be valuable to com- 2. Sanz M, Simion M (2014) Surgical techniques on periodontal plas-
pare CGF, which has been stated to have superior properties in tic surgery and soft tissue regeneration: consensus report of Group 3
of the 10th European Workshop on Periodontology. J Clin
in vitro studies, along with other PCs or regenerative mate-
Periodontol 41(Suppl):92–97. https://doi.org/10.1111/jcpe.12215
rials, such as enamel matrix derivate and collagen matrix, in 3. Cairo F, Nieri M, Pagliaro U (2014) Efficacy of periodontal plastic
terms of clinical effectiveness in periodontal plastic surgery. surgery procedures in the treatment of localized gingival recessions.
A systematic review J Clin Periodontol 41:44–62. https://doi.org/
10.1111/jcpe.12182
4. Griffin TJ, Cheung WS, Zavras AI, Damoulis PD (2006)
Postoperative complications following gingival augmentation pro-
Conclusion cedures. J Periodontol 77:2070–2079. https://doi.org/10.1902/jop.
2006.050296
The results obtained within the limits of this study showed that 5. Tavelli L, Barootchi S, Ravida A, Oh TJ, Wang HL (2019) What is
CGF, which did not require a second donor site on the palate, the safety zone for palatal soft tissue graft harvesting based on the
was cost-effective, prevented complications after harvesting locations of the greater palatine artery and foramen? A systematic
review. J Oral Maxillofac Surg 77(2):271.e1–271.e9. https://doi.
CTG, and did not improve the root coverage as much as org/10.1016/j.joms.2018.10.002
CTG in the treatment of Miller Class I and II GR. CGF could 6. Moraschini V, Barboza E (2016) Use of platelet-rich fibrin mem-
not serve as a direct alternative biomaterial to the gold stan- brane in the treatment of gingival recession: a systematic review
dard CTG. CGF can be applied in cases with contraindication and meta-analysis. J Periodontol 87:281–290. https://doi.org/10.
1902/jop.2015.150420
to CTG harvesting from the palate and in cases where the 7. Aroca S, Keglevich T, Barbieri B, Gera I, Etienne D (2009) Clinical
patient and clinician want to reduce morbidity, and are willing evaluation of a modified coronally advanced flap alone or in com-
to accept less than optimal results. However, this finding is not bination with a platelet-rich fibrin membrane for the treatment of
sufficient to advocate the true clinical effects of CGF on gin- adjacent multiple gingival recessions: a 6-month study. J
Periodontol 80:244–252. https://doi.org/10.1902/jop.2009.080253
gival recession treatment with TT. More studies are needed to 8. Bozkurt Dogan Ş, Dede FO, Ballı U, Atalay EN, Durmuşlar M
investigate and compare the effectiveness of CGF in terms of (2015) Concentrated growth factor in the treatment of adjacent
root coverage. multiple gingival recessions: a split-mouth randomized clinical tri-
al. J Clin Periodontol 42(9):868–875. https://doi.org/10.1111/jcpe.
12444
9. Uzun BC, Ercan E, Tunalı M (2018) Effectiveness and predictabil-
Acknowledgements The authors do not have any financial interest in the
ity of titanium-prepared platelet-rich fibrin for the management of
companies whose materials are included in this study.
multiple gingival recessions. Clin Oral Investig 22(3):1345–1354.
https://doi.org/10.1007/s00784-017-2211-2
Author contribution All authors have made substantial contributions to 10. Anitua E, Andia I, Ardanza B, Nurden P, Nurden A (2004)
conception and design of the study. BK contributed to the design of the Autologous platelets as a source of proteins for healing and tissue
study, treated the patients, analyzed the data, and wrote the manuscript regeneration. Thromb Haemost 91:14–15. https://doi.org/10.1160/
with input from the other author. UB was involved in data collection and TH03-07-0440
interpretation, and revised it critically. All authors have given final ap- 11. Rodella LF, Favero G, Boninsegna R, Buffoli B, Labanca M, Scarì
proval of the version to be published. G, Sacco L, Batani T, Rezzani R (2011) Growth factors, CD34
positive cells, and fibrin network analysis in concentrated growth
Funding This study was supported by the Scientific Research Fund of factors fraction. Microsc Res Tech 74(8):772–777. https://doi.org/
Bulent Ecevit University in Zonguldak/TURKEY (Project Number: 10.1002/jemt.20968
2017-62550515-01). 12. Sohn DS, Heo JU, Kwak DH, Kim DE, Kim JM, Moon JW, Lee
JH, Park IS (2011) Bone regeneration in the maxillary sinus using
Declarations an autologous fibrin-rich block with concentrated growth factors
alone. Implant Dent 20(5):389–395. https://doi.org/10.1097/ID.
0b013e31822f7a70
Ethics approval All the procedures performed in the study involving 13. Qiao J, Na A, Ouyang X (2017) Quantification of growth factors in
human participants were in accordance with the ethical standards of the
different platelet concentrates. Platelets 28(8):774–778. https://doi.
institutional and/or national research committee and with the 1964
org/10.1080/09537104.2016.1267338
Helsinki Declaration and its later amendments or comparable ethical
14. Bonazza V, Hajistilly C, Patel D, Patel J, Woo R, Cocchi MA,
standards.
Buffoli B, Lancini D, Gheno E, Rezzani R, Jahanzeb S, Hunnisett
A, Almasri M, Lucchina AG, Brucoli M, Mortellaro C, Rodella LF
Consent to participate Informed consent was obtained from all individ- (2018) Growth factors release from concentrated growth factors:
ual participants included in the study. effect of beta-Tricalcium phosphate addition. J Craniofac Surg
29(8):2291–2295. https://doi.org/10.1097/SCS.
Conflıct of interest The authors declare no competing interests. 0000000000004607
Clin Oral Invest (2021) 25:6347–6356 6355
15. Kim TH, Kim SH, Sándor GK, Kim Y (2014b) Comparison of 29. Zuhr O, Rebele SF, Schneider D, Jung RE, Hürzeler M (2014)
platelet-rich plasma (PRP), platelet-rich fibrin (PRF), and concen- Tunnel technique with connective tissue graft versus coronally ad-
trated growth factor (CGF) in rabbit-skull defect healing. Arch Oral vanced flap with enamel matrix derivative for root coverage: a RCT
Biol 59(5):550–558. https://doi.org/10.1016/j.archoralbio.2014.02. using 3D digital measuring methods. Part I Clinical and patient-
004 centred outcomes J Clin Periodontol 41:582–592. https://doi.org/
16. Park HC, Kim SG, Oh JS, You JS, Kim JS, Lim S (2016) Early 10.1111/jcpe.12178
bone formation at a femur defect using CGF and PRF grafts in adult 30. Aroca S, Keglevich T, Nikolidakis D, Gera I, Nagy K, Azzi R,
dogs: a comparative study. Implant Dent 25(3):387–393. https:// Etienne D (2010) Treatment of class III multiple gingival reces-
doi.org/10.1097/ID.0000000000000423 sions: a randomized-clinical trial. J Clin Periodontol 37(1):88–97.
17. Jin R, Guangtai S, Chai J, Gou X, Yuan G, Chen Z (2018) Effects of https://doi.org/10.1111/j.1600-051X.2009.01492.x
concentrated growth factor on proliferation, migration, and differ- 31. Zuhr O, Fickl S, Wachtel H, Bolz W, Hürzeler M (2007) Covering
entiation of human dental pulp stem cells in vitro. J Tissue Eng 9(3). of gingival recessions with a modified microsurgical tunnel tech-
doi:https://doi.org/10.1177/2041731418817505 nique: case report. Int J Periodontics Restorative Dent 27:457–463
18. Yu B, Wang Z (2014) Effect of concentrated growth factors on 32. Santamaria MP, Neves F, Silveira CA et al (2017) Connective
beagle periodontal ligament stem cells in vitro. Mol Med Rep tissue graft and tunnel or trapezoidal flap for the treatment of single
9(1):235–242. https://doi.org/10.3892/mmr.2013.1756 maxillary gingival recessions: a randomized clinical trial. J Clin
19. Lee HM, Shen EC, Shen JT, Fu E, Chiu HC (2020) Tensile Periodontol 44:540–547. https://doi.org/10.1111/jcpe.12714
strength, growth factor content and proliferation activities for two 33. McGuire MK, Scheyer ET (2010) Xenogeneic collagen matrix with
platelet concentrates of platelet-rich fibrin and concentrated growth coronally advanced flap compared to connective tissue with
factor. J Dent Sci 15:141–146. https://doi.org/10.1016/j.jds.2020. coronally advanced flap for the treatment of dehiscence- type re-
03.011 cession defects. J Periodontol 81:1108–1117. https://doi.org/10.
20. Takahashi A, Tsujino T, Yamaguchi S, Isobe K, Watanabe T, 1902/jop.2010.090698
Kitamura Y, Okuda K, Nakata K, Kawase T (2019) Distribution 34. Eren G, Atilla G (2014) Platelet-rich fibrin in the treatment of lo-
of platelets, transforming growth factor-β1, platelet-derived growth calized gingival recessions: a split-mouth randomized clinical trial.
factor-BB, vascular endothelial growth factor and matrix Clin Oral Investig 18:1941–1948. https://doi.org/10.1007/s00784-
metalloprotease-9 in advanced platelet-rich fibrin and concentrated 013-1170-5
growth factor matrices. J Investig Clin Dent 10(4):e12458. https:// 35. O’Leary TJ, Drake RB, Naylor JE (1972) The plaque control re-
doi.org/10.1111/jicd.12458 cord. J Periodontol 43:38. https://doi.org/10.3290/j.qi.a28739
21. Yu M, Wang X, Liu Y, Qiao J (2019) Cytokine release kinetics of 36. Ainamo J, Bay I (1975) Problems and proposals for recording gin-
concentrated growth factors in different scaffolds. Clin Oral givitis and plaque. Int Dent J 25:229–235
Investig 23(4):1663–1671. https://doi.org/10.1007/s00784-018- 37. Naik AR, Ramesh AV, Dwarkanath CD, Naik MS, Chinnappa AB
2582-z (2013) Use of autologous platelet rich plasma to treat gingival re-
22. Sohn DS, Moon JW, Moon YS, Park JS, Jung H (2009) The use of cession in esthetic periodontal surgery. J Indian Soc Periodontol 17:
concentrated growth factor (CGF) for sınus augmentation. J Oral 345–353. https://doi.org/10.4103/0972-124X.115665
Implant Sci 38:25–38 38. Zucchelli G, Mele M, Stefanini M, Mazzotti C, Marzadori M,
23. Honda H, Tamai N, Naka N, Yoshikawa H, Myoui A (2013) Bone Montebugnoli L, De Sanctis M (2010) Patient morbidity and root
tissue engineering with bone marrow-derived stromal cells integrat- coverage outcome after subepithelial connective tissue and de-
ed with concentrated growth factor in Rattus norvegicus calvaria epithelialized grafts: a comparative randomized-controlled clinical
defect model. J Artif Organs 16:305–315. https://doi.org/10.1007/ trial. J Clin Periodontol 37(8):728–738. https://doi.org/10.1111/j.
s10047-013-0711-7 1600-051X.2010.01550.x
24. Masuki H, Okudera T, Watanebe T, Suzuki M, Nishiyama K, 39. Zuhr O, Rebele SF, Thalmair T, Fickl S, Hürzeler M (2009) A
Okudera H, Nakata K, Uematsu K, Su CY, Kawase T (2016) modified suture technique for plastic periodontal and implant
Growth factor and pro-inflammatory cytokine contents in platelet- surgery-the double-crossed suture. Eur J Esthet Dent 4(4):338–347
rich plasma (PRP), plasma rich in growth factors (PRGF), advanced 40. Clark R (2001) Fibrin and wound healing. Ann N Y Acad Sci 936:
platelet-rich fibrin (A-PRF), and concentrated growth factors 355–367. https://doi.org/10.1111/j.1749-6632.2001.tb03522.x
(CGF). Int J Implant Dent 2:19. https://doi.org/10.1186/s40729- 41. Lafzi A, Faramarzi M, Shirmohammadi A, Behrozian A,
016-0052-4 Kashefimehr A, Khashabi E (2012) Subepithelial connective tissue
25. Lei L, Yu Y, Han J, Shi D, Sun W, Zhang D, Chen L (2020) graft with and without the use of plasma rich in growth factors for
Quantification of growth factors in advanced platelet-rich fibrin treating root exposure. J Periodontal Implant Sci 42:196–203.
and concentrated growth factors and their clinical efficiency as https://doi.org/10.5051/jpis.2012.42.6.196
adjunctive to the GTR procedure in periodontal intrabony defects. 42. Akcan SK, Unsal B (2020) Gingival recession treatment with con-
J Periodontol 91(4):462–472. https://doi.org/10.1002/JPER.19- centrated growth factor membrane: a comparative clinical trial. J
0290 Appl Oral Sci 28. https://doi.org/10.1590/1678-7757-2019-0236
26. Tabatabaei F, Aghamohammadi Z, Tayebi L (2020) In vitro and 43. Del Fabbro M, Bortolin M, Taschieri S, Weinstein R (2011) Is
in vivo effects of concentrated growth factor on cells and tissues. J platelet concentrate advantageous for the surgical treatment of peri-
Biomed Mater Res Part A 108(6):1338–1350. https://doi.org/10. odontal diseases? A systematic review and meta-analysis. J
1002/jbm.a.36906 Periodontol 82(8):1100–1111. https://doi.org/10.1902/jop.2010.
27. Xu Y, Qiu J, Sun Q, Yan S, Wang W, Yang P, Song A (2019) One 100605
year results evaluating the effects of concentrated growth factors on 44. Luo HY, Li RM, Wang CL, Peng L, Ye L (2015) The adjunctive
the healing of intrabony defects treated with or without bone sub- use of platelet concentrates in the therapy of gingival recessions: a
stitute in chronic periodontitis. Med Sci Monit 25:4384–4389. systematic review and meta-analysis. J Oral Rehabil 42:52–561.
https://doi.org/10.12659/MSM.917025 https://doi.org/10.1111/joor.12278
28. Zuhr O, Rebele SF, Cheung SL (2000) Hürzeler M (2018) Surgery 45. Castro AB, Meschi N, Temmerman A, Pinto N, Lambrechts P,
without papilla incision: tunneling flap procedures in plastic peri- Teughels W, Quirynen M (2017) Regenerative potential of
odontal and implant surgery. Periodontol 77(1):123–149. https:// leucocyte- and platelet-rich fibrin. Part A:intra-bony defects, furca-
doi.org/10.1111/prd.12214 tion defects and periodontal plastic surgery. A systematic review
6356 Clin Oral Invest (2021) 25:6347–6356
and meta- analysis J Clin Periodontol 44(1):67–82. https://doi.org/ 54. Pazmiño VF, Rodas MA, Cáceres CD et al (2017) Clinical com-
10.1111/jcpe.12643 parison of the subepithelial connective tissue versus platelet-rich
46. Miron RJ, Moraschini V, Del Fabbro M et al (2020) Use of platelet- fibrin for the multiple gingival recession coverage on anterior teeth
rich fibrin for the treatment of gingival recessions: a systematic using the tunneling technique. Case Rep Dent 4949710:1–6. https://
review and meta-analysis. Clin Oral Investig 2020 24(8):2543– doi.org/10.1155/2017/4949710
2557. https://doi.org/10.1007/s00784-020-03400-7 55. Moisa DH, Connolly JA, Cheng B, Lalla E (2019) Impact of con-
47. Jenabian N, Motallebnejad M, Zahedi E, Sarmast ND, Angelov N nective tissue graft thickness on surgical outcomes: a pilot random-
(2018) Coronally advanced flap and without plasma rich in growth ized clinical trial. J Periodontol 90(9):966–972. https://doi.org/10.
factors (PRGF) in treatment of gingival recession. J Clin Exp Dent 1002/JPER.18-0741
10(5):431–438. https://doi.org/10.4317/jced.54573 56. Del Corso M, Sammartino G, Dohan Ehrenfest DM (2009) Letter to
48. Dohan Ehrenfest DM, Pinto NR, Pereda A, Jiménez P, Corso MD, the Editor: Re: “Clinical Evaluation of a Modified Coronally
Kang BS, Nally M, Lanata N, Wang HL, Quirynen M (2018) The Advanced Flap Alone or in Combination With a Platelet-Rich
impact of the centrifuge characteristics and centrifugation protocols Fibrin Membrane for the Treatment of Adjacent Multiple
on the cells, growth factors, and fibrin architecture of a leukocyte- Gingival Recessions: A 6-Month Study”. J Periodontol 80:1694–
and platelet-rich fibrin (L-PRF) clot and membrane. Platelets 29(2): 1697. https://doi.org/10.1902/jop.2009.090253
1–14. https://doi.org/10.1080/09537104.2017.1293812 57. Culhaoglu R, Taner L, Guler B (2018) Evaluation of the effect of
49. Miron RJ, Pinto NR, Quirynen M, Ghanaati S (2019) dose-dependent platelet-rich fibrin membrane on treatment of gin-
Standardization of relative centrifugal forces in studies related to gival recession: a randomized, controlled clinical trial. J Appl Oral
platelet-rich fibrin. J Periodontol 99:817–820. https://doi.org/10. Sci 26. https://doi.org/10.1590/1678-7757-2017-0278
1002/JPER.18-0553 58. Jankovic S, Aleksic Z, Klokkevold P, Lekovic V, Dimitrijevic B,
50. Hong S, Chen W, Jiang B (2018) A comparative evaluation of Kenney EB, Camargo P (2012) Use of platelet-rich fibrin mem-
concentrated growth factor and platelet-rich fibrin on the prolifera- brane following treatment of gingival recession: a randomized clin-
tion, migration, and differentiation of human stem cells of the apical ical trial. Int J Periodontics Restorative Dent 32(2):41–50
papilla. J Endod 44(6):977–983. https://doi.org/10.1016/j.joen.
59. Öncü E (2017) The use of platelet-rich fibrin versus subepithelial
2018.03.006
connective tissue graft in treatment of multiple gingival recessions:
51. Miron RJ, Fujioka-Kobayashi M, Bishara M, Zhang M, Hernandez
a randomized clinical trial. Int J Periodontics Restorative Dent 37:
M, Choukroun J (2017) Platelet-rich fibrin and soft tissue wound
265–271. https://doi.org/10.11607/prd.2741
healing: a systematic review. Tissue Eng Part B Rev 23(1):83–99.
60. Keceli HG, Kamak G, Erdemir EO, Evginer MS, Dolgun A (2015)
https://doi.org/10.1089/ten.teb.2016.0233
The adjunctive effect of platelet-rich fibrin to connective tissue graft
52. Zumara´n CC, Parra MV, Olate SA, Ferna´ndez EG (2018) The 3
in the treatment of buccal recession defects: results of a randomized,
R’s for Platelet-Rich Fibrin: a ‘super’ tridimensional biomaterial for
parallel group controlled trial. J Periodontol 86(11):1221–1230.
contemporary naturally-guided oro-maxillo-facial soft and hard tis-
sue repair, reconstruction and regeneration. Materials 11: 1293. doi: https://doi.org/10.1902/jop.2015.150015
https://doi.org/10.3390/ma11081293 61. Karring T, Lang NP, Löe H (1975a) The role of gingival connective
53. Tavelli L, Barootchi S, Nguyen TVN, Tattan M, Ravida A, Wang tissue in determining epithelial differentiation. J Periodontal Res 10:
HL (2018) Efficacy of tunnel technique in the treatment of localized 1–11. https://doi.org/10.1111/j.1600-0765.1975.tb00001.x
and multiple gingival recessions: a systematic review and a meta-
analysis. J Periodontol 89(9):1075–1090. https://doi.org/10.1002/ Publisher’s note Springer Nature remains neutral with regard to jurisdic-
JPER.18-0066 tional claims in published maps and institutional affiliations.